Weight loss reduces mechanical stress on weight-bearing joints, with each pound lost decreasing knee loading by approximately 3-4 pounds during walking
Liraglutide (Saxenda) Liraglutide works along the same GLP-1 pathway as semaglutide but is taken daily rather than weekly
First, it helps expand Lilly's leadership in the weight loss and diabetes treatment categories with another likely blockbuster drug
Final Thought: A Canadian Case Study in Market Exclusivity for Innovative Drugs This case study highlights the importance of securing a patent portfolio in Canada to utilize the patent linkage system, and other regulatory tools, to delay entry of generic competitors, which inevitably affects pricing across North America
This combination approach aligns with contemporary diabetes management strategies that address multiple pathophysiological defects simultaneously, potentially improving overall glycaemic control whilst managing weighta significant concern for many individuals with type 2 diabetes
This suggests that DPP-4 inhibitors, which are commonly used for treating type 2 diabetes mellitus (T2DM), may offer therapeutic benefits beyond glycemic control, potentially mitigating bone resorption and reducing fracture risk [23]